Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 153 points (1.0%) at 15,892 as of Thursday, Jan. 30, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 2,359 issues advancing vs. 580 declining with 163 unchanged. The Energy industry currently sits up 0.5% versus the S&P 500, which is up 1.0%. Top gainers within the industry include Pioneer Natural Resources Company ( PXD), up 2.9%, Spectra Energy ( SE), up 2.3%, Tenaris ( TS), up 2.0%, Enterprise Products Partners ( EPD), up 1.7% and Ecopetrol S.A ( EC), up 1.7%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Core Laboratories N.V ( CLB) is one of the companies pushing the Energy industry lower today. As of noon trading, Core Laboratories N.V is down $8.99 (-4.8%) to $177.00 on heavy volume. Thus far, 425,976 shares of Core Laboratories N.V exchanged hands as compared to its average daily volume of 201,300 shares. The stock has ranged in price between $172.41-$191.49 after having opened the day at $189.99 as compared to the previous trading day's close of $185.99. Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. Core Laboratories N.V has a market cap of $8.5 billion and is part of the basic materials sector. The company has a P/E ratio of 37.2, above the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Core Laboratories N.V a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Core Laboratories N.V as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Core Laboratories N.V Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.